Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

591 ARTÍCULOS , VIENDO DEL 346 AL 360

Brexpiprazole's impacts on patients and caregivers in agitation in Alzheimer's dementia

Nakamura Y, Adachi J, Hirota N, Iba K, Sasajima C, Shimizu K, Nakai M, Takahashi K.

Alzheimers Dement. 2025 Jul;21(7):e70522. doi: 10.1002/alz.70522.

Escitalopram for agitation in Alzheimer's dementia: a randomized controlled phase 3 trial

Rajji TK, Baksh SN, Shade DM, Ismail Z, Burhan AM, Okhravi HR, Padala PR, Rosenberg PB, Schneider LS, Porsteinsson AP, Lyketsos CG; S-CitAD Research Group.

Nat Med. 2025 May;31(5):1586-1591. doi: 10.1038/s41591-025-03569-y. Epub 2025 Mar 25.

Implementing early detection of cognitive impairment in primary care to improve care for older adults

Fowler NR, Partrick KA, Taylor J, Hornbecker M, Kelleher K, Boustani M, Cummings JL, MacLeod T, Mielke MM, Brosch JR, Lee J, Shobin E, Galvin JE, Fillit H, Udeh-Momoh C, Willis DR.

J Intern Med. 2025 Jul;298(1):31-45. doi: 10.1111/joim.20098. Epub 2025 May 23.

Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography Positivity

Moscoso A, Heeman F, Raghavan S, Costoya-Sánchez A, van Essen M, Mainta I, Camacho V, Rodríguez-Fonseca O, Silva-Rodríguez J, Perissinotti A, Gu Y, Yun J, Peretti D, Ribaldi F, Coomans EM, Brum WS, Grothe MJ, Aguiar P, Bischof GN, Drzezga A, Seo SW, Villeneuve S, Malpetti M, O'Brien JT, Rowe JB, van de Giessen EM, Ossenkoppele R, Jagust WJ, Smith R, Hansson O, Frisoni GB, Garibotto V, Soleimani-Meigooni DN, Carrillo M, Dickerson BC, La Joie R, Rabinovici GD, Apostolova LG, LaMontagne PJ, Pontecorvo MJ, Johnson KA, Sperling RA, Weiner MW, Petersen RC, Jack CR Jr, Vemuri P, Schöll M; PREVENT-AD Research Group, the Harvard Aging Brain Study, the LEADS Consortium, and the Alzheimer’s Disease Neuroimaging Initiative.

JAMA. 2025 Jul 15;334(3):229-242. doi: 10.1001/jama.2025.7817.

The Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care

Dickerson BC, Atri A, Clevenger C, Karlawish J, Knopman D, Lin PJ, Norman M, Onyike C, Sano M, Scanland S, Carrillo M.

Alzheimers Dement. 2025 Jan;21(1):e14337. doi: 10.1002/alz.14337. Epub 2024 Dec 23.

Deferiprone in Alzheimer Disease: A Randomized Clinical Trial

Ayton S, Barton D, Brew B, Brodtmann A, Clarnette R, Desmond P, Devos D, Ellis KA, Fazlollahi A, Fradette C, Goh AMY, Kalinowski P, Kyndt C, Lai R, Lim YY, Maruff P, O'Brien TJ, Rowe C, Salvado O, Schofield PW, Spino M, Tricta F, Wagen A, Williams R, Woodward M, Bush AI.

JAMA Neurol. 2025 Jan 1;82(1):11-18. doi: 10.1001/jamaneurol.2024.3733.

Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for primary care

Atri A, Dickerson BC, Clevenger C, Karlawish J, Knopman D, Lin PJ, Norman M, Onyike C, Sano M, Scanland S, Carrillo M.

Alzheimers Dement. 2025 Jun;21(6):e14333. doi: 10.1002/alz.14333. Epub 2024 Dec 23.

Disclosure of elevated amyloid status is not associated with long-term suicidality in a preclinical AD trial

Grill JD, Raman R, Flournoy C, Ernstrom K, Pierce A, Smith A, Rosenberg P, Burns J, Karlawish J, Aisen P, Holdridge KC, Mancini M, Sperling R, Sultzer D; A4 Study Team.

Alzheimers Dement. 2025 Feb;21(2):e14623. doi: 10.1002/alz.14623.

[A case of neuronal intranuclear inclusion disease with coexisting Alzheimer's disease biomarker signature in cerebrospinal fluid]

Ono N, Maruyama G, Akaiwa Y, Nakamura T, Tamai C, Sone J, Miyamoto T.

Rinsho Shinkeigaku. 2025 Dec 19;65(12):912-915. doi: 10.5692/clinicalneurol.cn-002153. Epub 2025 Nov 22.

Associations of plasma Neurofilament light chain with sarcopenia and physical capacity in patients with Alzheimer's diseases

Qaisar R, Karim A, Iqbal MS, Alkahtani SA, Ahmad F.

Acta Neurol Belg. 2025 Jun;125(3):691-698. doi: 10.1007/s13760-025-02759-2. Epub 2025 Mar 11.

Cognitive and neurodegenerative trajectories of subjective cognitive decline according to baseline biomarkers: Results of the CoSCo study

Hong YJ, Choi SH, Kim S, Jeong JH, Park KH, Wang MJ, Kang S, Yang DW; CoSCo study group.

Alzheimers Dement. 2025 Feb;21(2):e14473. doi: 10.1002/alz.14473. Epub 2024 Dec 28.

[News on blood biomarker-based early diagnosis of the preliminary stages of Alzheimer's dementia]

Hansen N, Wiltfang J.

Fortschr Neurol Psychiatr. 2025 Nov;93(11):446-452. doi: 10.1055/a-2698-5992. Epub 2025 Nov 6.

Identifying sex- and gender-specific endocrinological, lifestyle, psychosocial, and socio-cultural targets for Alzheimer's disease prevention in Africans: The Female Brain Health and Endocrine Research in Africa (FemBER-Africa) project

Udeh-Momoh CT, Aliwa B, Atwoli L, Blackmon K, Bosire E, Gitau S, Kaleli H, Kamanda C, Khakali L, Maina R, Mativo P, Mbugua S, Merali Z, Muchungi K, Njogu N, Nyankira D, Okech V, Ondieki A, Onyancha C, Onyango SO, Shah J, Shah S, Smith C, Sokhi D, Waa S, Gregory S, Hill-Jarrett TG, Kafetsouli D, Mielke MM, Muniz-Terrera G, Solomon A, Thesen T, Tsoy E, Yasoda-Mohan A, Yokoyama JS, Watermeyer TJ.

Alzheimers Dement. 2025 Nov;21(11):e70887. doi: 10.1002/alz.70887.

Cerebrospinal fluid acetylcholine is not a reliable diagnostic marker for Alzheimer's disease and dementia with Lewy bodies

Aveneau C, Lamy E, Grassin-Delyle S, Sanchez-Ortiz M, Vicaut E, Touchard C, Cognat E, Dumurgier J, Hourregue C, Hugon J, Bouaziz-Amar E, Paquet C.

J Alzheimers Dis. 2025 Dec;108(3):1339-1346. doi: 10.1177/13872877251387159. Epub 2025 Oct 22.

High circulating adropin levels predict long-term blood pressure variability in old adults: evidence from the Multidomain Alzheimer Prevention Trial

Aggarwal G, Salas J, Vellas B, Nguyen AD, Butler AA; MAPT/IHU HealthAge Open Science Group.

Am J Physiol Heart Circ Physiol. 2025 Dec 1;329(6):H1684-H1692. doi: 10.1152/ajpheart.00763.2025. Epub 2025 Nov 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias